The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Really good post Trinityman. Totally agree, I've been saying 90% + probability of launch for over a year now given the facts surrounding SNG001, so I'm pleased everyone seems to be aligning on this now. 95% is possible given last few months of activity.
Basically, It's fear of the "unknown voyage" through a scientific breakthrough inflection point, that is SNG001....nobody can predict with any robust degree of accuracy the upside revenue potential for this technology company and one can drive a bus through professional broker estimates of the upside outcomes. Makes for fascinating watching from the side lines awaiting very pivotal news. IMV the current SP equates to almost a complete failure scenario if you think about it, (GBP 370m Mkt Cap), which represents probably only the 10% max of the lower case scenarios that can be generated. So, strap in, enjoy the journey knowing you: (1) are part of a major scientific event in coming days/weeks that may transform the global respiratory ID secondary care sector; (2) change your own life for the better financially. GL DYOR.
Nellie "but sick and tired..... without a shred of concrete evidence."
NB. You will NEVER have as much affirmative publicly available evidence and information surrounding a Phase III trial readout PRE READOUT (commercial, scientific, Web site, massive new employee search, ashfield engage, interview positivity, subtle messaging from C suite, polygon large stake share purchases, unmet global market needs, etc shall I go on?) as SNG001 at this time so I doubt your statement holds water.
FTC - not necessarily because most knowledgeable and the less-risk averse investors are already heavily invested here with no willingness really to materially uplift exposures (e,g, me) so awaiting the news not many diverse PI buyers....but if there is a bigger buyer II or company buying in then maybe the only way to go is down to stimulate fear sales
Are the MMs struggling to get shares from sticky hands and hence having to crash the price to build selling fears??
What do the techies believe viewing the behind the scenes buys and sells details - maybe Monday is big announcement day? Views pls
Without launched SNG001 turbo immune-charger treatment, the virus is streets ahead of mankind, based on its agile global mutation capability, already with a strong hold into the massive global pool of human easy prey, multi-geography travelling multi-social so called 'intelligent' hosts...
Fantastic news. We are potentially a key pillar of the future USA (and by simple logic = global) pandemic therapeutic weaponry. IF readout is moderate, good or excellent SNG001 will be a very important BRIDGE as an immune modulation / enhancement drug that side steps the necessity to specifically deeply understand the structure and function of emerging viral coat spike antigens and synthesise targetted vaccines or monoclonals. So since new mutations can cross the globe in 1 to 2 weeks after their birth then governments economically cannot do without a stock pile of antiviral SNG001 rocket launchers. QED
I don't think that is possible, but I'm not sure if nods and winks cannot be used between past collaborators and friends like AZN. This is what I'm thinking too. Unsurprising if at the date of the RNS a suitor then arrives fairly immediately with a pre-concocted deal structure and they just refine the price a bit once they see the headline efficacy and safety so they can be the first bidder on the scene.
Tomorrow may be a good RNS day. 2 x 18hr days for the c suite team then relax at weekend before 5 x 12 hr days next week. I would do this because every man and dog maybe hounding them for interviews and coments for 1 week at least continually. Its a breakwater. See you at 7.02am